Stay updated on Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Sign up to get notified when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The study record history now shows the latest revision as v3.6.6, replacing the previous v3.6.5. This reflects an update to the ClinicalTrials.gov record display for the nct03836066 page.
    Difference
    0.1%
    Check dated 2026-08-31T17:51:24.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    23 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    A new revision entry v3.6.5 is added to the study record history, superseding the previous v3.6.4.
    Difference
    0.1%
    Check dated 2026-08-10T13:44:38.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    A new revision entry v3.6.4 is added to the history. The previous v3.6.3 is removed from the list, updating the page's version history.
    Difference
    0.1%
    Check dated 2026-07-27T05:52:58.000Z thumbnail image
  7. Check
    66 days ago
    Change Detected
    Summary
    A new revision entry labeled v3.6.3 was added to the study record's version history, and the previous revision v3.6.2 was removed, updating the historical record for the study.
    Difference
    0.1%
    Check dated 2026-07-05T13:57:23.000Z thumbnail image
  8. Check
    74 days ago
    Change Detected
    Summary
    A new revision label v3.6.2 was added to the study record history, and the older v3.6.0 entry was removed from the log.
    Difference
    0.1%
    Check dated 2026-06-28T08:25:52.000Z thumbnail image
  9. Check
    88 days ago
    Change Detected
    Summary
    Enrollment is closed to new participants, reflecting a recruitment-status update on the study page. The record has been updated to include the latest revision tag v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-14T03:59:21.000Z thumbnail image

Stay in the know with updates to Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Atezolizumab+Bevacizumab 1st Line in NSCLC (TELMA) Clinical Trial page.